Literature DB >> 20306731

Adenosine deaminase activity in subjects with normal pregnancy, pregnancy induced hypertension and pre-eclampsia.

O O Oladipo1, B B Afolabi, A O Okorodudu.   

Abstract

BACKGROUND: Both pregnancy and adenosine deaminase (ADA) are associated with depressed cellular mediated immunity. There is little information on ADA activity in pregnant Africans.
OBJECTIVE: To determine the serum levels of adenosine deaminase (ADA) in normal pregnancy and pregnancy complicated by hypertension in Nigerian women.
METHODS: One hundred and twenty-five pregnant women comprising 35 normal non-pregnant women, 35 normal pregnant women, 35 pregnant women with pregnancy induced hypertension and 20 patients with pre-eclampsia were recruited for the study. Serum adenosine deaminase enzyme (ADA) activity was measured by the Giusti and Galanti spectrophotometric method in all study subjects.
RESULTS: The mean serum ADA level in the non-pregnant women was higher than that in the normal pregnant women (23.21 +/- 6.3 v 14.69 +/- 3.2, p<0.001). Amongst the pregnant women, mean serum ADA in the hypertensive and pre-eclamptic women was significantly higher than that in the normal pregnant group (p<0.001).
CONCLUSION: These findings indicate a probable decrease in cellular immunity in normal pregnancy and an enhanced cell mediated immunity in pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20306731     DOI: 10.4314/wajm.v28i3.48441

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  4 in total

1.  Serum adenosine deaminase and its isoenzyme activities in pregnancy.

Authors:  Göksel Bahadır; Yasemin Erdoğan Döventaş; Rana Turkal; Macit Koldaş; Filiz Basınoğlu; Banu Dane; Emine Altunkaynak
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

2.  Determination of serum adenosine deaminase and xanthine oxidase activity in Kangal dogs with maternal cannibalism.

Authors:  N Ercan; M Koçkaya; S Kapancik; D Bakir
Journal:  Vet World       Date:  2017-11-15

Review 3.  The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.

Authors:  Margarete Dulce Bagatini; Alessandra Antunes Dos Santos; Andréia Machado Cardoso; Aline Mânica; Cristina Ruedell Reschke; Fabiano Barbosa Carvalho
Journal:  J Immunol Res       Date:  2018-08-12       Impact factor: 4.818

Review 4.  Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.

Authors:  Barbara Kutryb-Zajac; Paulina Mierzejewska; Ewa M Slominska; Ryszard T Smolenski
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.